PMID- 12618146 OWN - NLM STAT- MEDLINE DCOM- 20030926 LR - 20190922 IS - 0143-4160 (Print) IS - 0143-4160 (Linking) VI - 33 IP - 4 DP - 2003 Apr TI - Intracellular Ca(2+) regulates the cellular iron uptake in K562 cells. PG - 257-66 AB - Fluorescence quenching was used to study the kinetics of the transferrin receptor (TfR)-mediated iron uptake in the calcein-loaded K562 cells. It was found that elevation of intracellular free Ca(2+) ([Ca(2+)](i)) by thapsigargin (TG) speeds up the initial rate of iron uptake and increases the overall capacity of the cells in taking up iron. Depletion of intracellular Ca(2+) or complete chelation of extracellular Ca(2+) results in complete inhibition of the iron uptake in cells. To gain insight into molecular mechanism, IANBD-labeled transferrin (Tf) and microscopic fluorescence imaging were used to observe the endocytosis and recycling of the Tf-TfR complex in single live cells. The study showed that the preincubation of cells with TG or phorbol myristate acetate (PMA), the direct activator of protein kinase C (PKC), accelerated the endocytosis and recycling of the complex in a dose-dependent manner. W-7, the calmodulin antagonist, and GF109203X, a selected cell-permeant inhibitor of PKC, can reverse the acceleration. Analysis of actin polymerization in controlled, [Ca(2+)](i)-elevated and W-7-treated cells revealed that the actin polymerization is enhanced as [Ca(2+)](i) is raised, but reduced by W-7. The results suggest that the regulation of actin polymerization by intracellular Ca(2+) may play a central role in Ca(2+)-dependent iron uptake. FAU - Ci, Weimin AU - Ci W AD - Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing 100101, China. FAU - Li, Wenyu AU - Li W FAU - Ke, Ya AU - Ke Y FAU - Qian, Zhong-Ming AU - Qian ZM FAU - Shen, Xun AU - Shen X LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Cell Calcium JT - Cell calcium JID - 8006226 RN - 0 (Actins) RN - 0 (Chelating Agents) RN - 0 (Enzyme Inhibitors) RN - 0 (Fluoresceins) RN - 0 (Oxadiazoles) RN - 0 (Polymers) RN - 0 (Receptors, Transferrin) RN - 0 (Transferrin) RN - 67013-48-3 (4-(N-(iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole) RN - E1UOL152H7 (Iron) RN - EC 2.7.11.13 (Protein Kinase C) RN - SY7Q814VUP (Calcium) RN - V0YM2B16TS (fluorexon) SB - IM MH - Actins/biosynthesis/drug effects MH - Calcium/*metabolism MH - Calcium Signaling/drug effects/*physiology MH - Chelating Agents/pharmacology MH - Endocytosis/drug effects/*physiology MH - Enzyme Inhibitors/pharmacology MH - Eukaryotic Cells/drug effects/*metabolism MH - Fluoresceins MH - Humans MH - Intracellular Fluid/drug effects/*metabolism MH - Iron/*metabolism MH - Oxadiazoles MH - Polymers/metabolism MH - Protein Kinase C/drug effects/metabolism MH - Receptors, Transferrin/drug effects/*metabolism MH - Transferrin/metabolism MH - Tumor Cells, Cultured MH - Up-Regulation/drug effects/physiology EDAT- 2003/03/06 04:00 MHDA- 2003/09/27 05:00 CRDT- 2003/03/06 04:00 PHST- 2003/03/06 04:00 [pubmed] PHST- 2003/09/27 05:00 [medline] PHST- 2003/03/06 04:00 [entrez] AID - S0143416002002403 [pii] AID - 10.1016/s0143-4160(02)00240-3 [doi] PST - ppublish SO - Cell Calcium. 2003 Apr;33(4):257-66. doi: 10.1016/s0143-4160(02)00240-3.